Concepedia
Statistics
Publications
31
Citations
869
H-Index
20
Active since
1989
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Germany)
Bristol-Myers Squibb (Sweden)
Loughborough University
AstraZeneca (United Kingdom)
Carol A. Sargent is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and physiology.
Top concepts
MedicinePharmacologyPhysiologyCardiologyBiochemistryPharmacotherapyCardiovascular DiseaseNatural SciencesHeart FailureDrug Discovery
Publications per year
1989–2011
Cardioprotective Profile of the Cardiac-Selective ATP-Sensitive Potassium Channel Opener BMS-180448
Gary J. Grover, John R. McCullough, Albert J. DʼAlonzo et al. · Journal of Cardiovascular Pharmacology · 1995 · 65 citations
Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages
Jane Armstrong, Carol A. Sargent, Dave Singh · Clinical & Experimental Immunology · 2009 · 65 citations · Full text
Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat
Katherine J. Escott, MG Belvisi, Mark A. Birrell et al. · British Journal of Pharmacology · 2000 · 57 citations · Full text
Asthma, Inflammatory Lung Disease, Lung Inflammation +16
The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
G. J. Grover, Steven Dzwonczyk, Paul G. Sleph et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 55 citations
The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.
Carol A. Sargent, G. J. Grover, Michael J. Antonaccio et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 43 citations
1–5 of 31